Gatifloxacin
Products in Health Canada’s databases that list Gatifloxacin as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
Also listed as “Gatifloxacin (Gatifloxacin Hemihydrate)” (1). How names are joined
- Drug products
- 9
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 12
- Products in all
- 9
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| JAMP GATIFLOXACIN (0.3 %) | 02533235 | Marketed | JAMP Pharma Corporation | |
| ZYMAR (0.3 %) | 02257270 | Marketed | AbbVie Corporation | |
| APO-GATIFLOXACIN (0.3 %) | 02327260 | Dormant | Apotex Inc. | |
| NOVO-GATIFLOXACIN (400 MG) | 02271052 | Cancelled Pre Market | Novopharm Limited | |
| SANDOZ GATIFLOXACIN (3 MG) | 02408481 | Cancelled Pre Market | Sandoz Canada Inc. | |
| TEQUIN (200 MG) | 02243181 | Cancelled Post Market | Bristol-Myers Squibb Canada | |
| TEQUIN (400 MG) | 02243182 | Cancelled Post Market | Bristol-Myers Squibb Canada | |
| TEQUIN IV (2 MG) | 02243183 | Cancelled Post Market | Bristol-Myers Squibb Canada | |
| TEQUIN IV (10 MG) | 02243184 | Cancelled Post Market | Bristol-Myers Squibb Canada |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- JAMP GATIFLOXACINDecember 5, 2025 · NOC 36496
- APO-GATIFLOXACINAugust 10, 2023 · NOC 31412
- JAMP GATIFLOXACINDecember 29, 2022 · NOC 29786
- ZYMARAugust 15, 2022 · NOC 28753
- ZYMARMarch 11, 2022 · NOC 27744
- APO-GATIFLOXACINSeptember 26, 2019 · NOC 22695
- SANDOZ GATIFLOXACINAugust 21, 2019 · NOC 22705
- APO-GATIFLOXACINMarch 23, 2016 · NOC 18065
- ZYMARAugust 30, 2004 · NOC 5314
- TEQUINJuly 27, 2004 · NOC 4815
- TEQUINApril 16, 2002 · NOC 569
- TEQUINJanuary 9, 2001 · NOC 2301